NEURENTIS PLCActive
Key figures
NEURENTIS PLC does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.
Ratios
2024/25Balance sheet structure
Filed accounts2023/24–2024/25
| 2023/24 | 2024/25 | |
|---|---|---|
| Profit for the year | -37,469 | -43,267 |
| Cash at bank and in hand | 37,211 | 49,539 |
| Total assets | 87,973 | 70,901 |
| Total liabilities | 16,380 | 24,021 |
| Net assets / total equity | 2,085,489 | 2,052,222 |
| Average number of employees | 3 | 3 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: NEURENTIS PLC
Company
NEURENTIS PLC is a public limited company registered with Companies House under company number 14461527. It was incorporated on 4 Nov 2022. Its status is active. The registered office is in London (W9). Its nature of business (SIC 2007) is manufacture of basic pharmaceutical products (21100), manufacture of pharmaceutical preparations (21200).
Accounts
The latest accounts in the database are for 2024/25 (period ending 30 Nov 2025); the company files full accounts. Loss for the year was £43,267. Net assets were £2,052,222, down 1.6% on the previous year. Cash at bank and in hand was £49,539. Total assets were £70,901 and total liabilities £24,021. The company had an average of 3 employees. Figures are available for 2 financial years (2023/24–2024/25).
Control and charges
2 persons with significant control are registered.
Filing deadlines
The next accounts are due by 31 May 2027. The next confirmation statement is due by 20 Feb 2027.